Introduction Neuromuscular and functional electrical stimulation (NMES/FES) are widely used in spinal cord injury (SCI) rehabilitation to preserve muscle health, manage spasticity, and support functional recovery. However, stimulation protocols typically use fixed parameters with limited individualisation. The strength–duration (SD) curve, reflecting the relationship between pulse duration and stimulus intensity required for muscle contraction, captures excitability changes due to denervation, reinnervation, and training. While historically used in neurophysiology, its translational role in guiding NMES/FES programming in SCI rehabilitation remains unclear. This scoping review aims to map current evidence on SD-curve measurement, outcomes, and clinical applications in SCI.

Methods and analysis This protocol follows PRISMA-ScR guidelines. We will search MEDLINE, EMBASE, CINAHL, and grey literature sources from inception to present. Eligible studies will include adults with traumatic or non-traumatic SCI, reporting SD curves or related excitability measures (rheobase, chronaxie, accommodation index). Data extraction will capture study characteristics, methods of SD-curve measurement, rheobase/chronaxie values, clinical applications (diagnostic, prognostic, therapeutic), and outcomes of SD-guided NMES/FES interventions. Results will be presented descriptively and thematically, with tables and figures mapping measurement approaches, reported values, and translational applications. Methodological and reporting gaps will be highlighted.

Ethics and dissemination Ethical approval is not required. Findings will be disseminated through peer-reviewed publication, international conferences, and to inform future pilot studies on SD-curve–guided rehabilitation in SCI.

The authors have declared no competing interest.

https://doi.org/10.17605/OSF.IO/DU9GN

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes